Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | ||||
|---|---|---|---|---|---|
| Revenue | -11.43% | 22.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.43% | 22.39% | |||
| Cost of Revenue | -11.76% | 88.89% | |||
| Gross Profit | -11.39% | 17.67% | |||
| SG&A Expenses | 10.73% | 19.99% | |||
| Depreciation & Amortization | 2.67% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.14% | 22.00% | |||
| Operating Income | -125.54% | -19.31% | |||
| Income Before Tax | -407.41% | 50.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -407.41% | 50.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -407.41% | 50.32% | |||
| EBIT | -125.54% | -19.31% | |||
| EBITDA | -270.87% | -54.88% | |||
| EPS Basic | -100.00% | 81.82% | |||
| Normalized Basic EPS | -200.00% | 85.71% | |||
| EPS Diluted | -100.00% | 81.82% | |||
| Normalized Diluted EPS | -200.00% | 85.71% | |||
| Average Basic Shares Outstanding | 118.94% | 182.82% | |||
| Average Diluted Shares Outstanding | 118.94% | 182.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
